Catalyst Crew Technologies Advances Telehealth Platform Development for Latin American Markets
Catalyst Crew Technologies is developing an AI-integrated telehealth platform focused on emerging markets, starting with Venezuela, to improve healthcare coordination and data-driven insights in regions with growing demand for modernized medical services.
Catalyst Crew Technologies Corp. has provided an update on its telehealth platform development, highlighting progress toward creating digital health infrastructure for emerging markets with an initial focus on Latin America. The company's platform aims to support remote patient engagement, care coordination, and integration of artificial intelligence-driven healthcare analytics tools within technology-enabled healthcare environments.
The platform is designed to facilitate communication between patients, healthcare providers, and related service participants while supporting structured data collection and workflow coordination across multiple points of care. It is intended to integrate with the company's broader artificial intelligence healthcare platform, including CardioAI, PulmoAI, and NeuroAI modules being developed for data-driven analytics and clinical decision-support capabilities.
Development efforts are currently focused on establishing core platform functionality, including system architecture, data integration, user workflows, and operational processes. The company is evaluating approaches to support scalability, interoperability, and integration with existing healthcare systems and technologies. Catalyst Crew Technologies is leveraging its wholly-owned subsidiary in Venezuela to support local platform development, operational coordination, and infrastructure planning, with initial efforts focused on Venezuela and potential expansion into other Latin American markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated the company is focused on building a scalable and integrated telehealth platform that can support healthcare coordination and data-driven insights. The platform is intended to support healthcare providers and related service participants and does not replace licensed medical professionals or clinical decision-making.
The company continues to advance development of its digital health and artificial intelligence platform while evaluating opportunities for expansion across emerging markets. For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at https://www.sec.gov.